Filing Details
- Accession Number:
- 0000886163-14-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-01-02 16:48:28
- Reporting Period:
- 2013-12-31
- Filing Date:
- 2014-01-02
- Accepted Time:
- 2014-01-02 16:48:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 886163 | Ligand Pharmaceuticals Inc | LGND | Pharmaceutical Preparations (2834) | 770160744 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1392266 | S Charles Berkman | 11119 North Torrey Pines Road, Suite 200 La Jolla CA 92037 | Vp, Gen. Counsel & Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-12-31 | 209 | $33.92 | 27,145 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Shares Acquired under Ligand's employee stock purchase plan.
Billionaire Hedge Funds
